Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.58
+0.15 (2.02%)
At close: Aug 21, 2026, 4:00 PM EDT
7.74
+0.16 (2.11%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $51.41 million as of August 21, 2026. Its market cap has decreased by -69.94% in one year.
Market Cap
51.41M
Enterprise Value
69.15M
1-Year Change
-69.94%
Ranking
Category
Stock Price
$7.58
ChartMarket Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $51.41M, a decrease of -97.96%. That is a compound annual growth rate of -51.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 51.41M | -31.09% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 53.51M |
| aTyr Pharma | 52.26M |
| Apollomics | 51.80M |
| TScan Therapeutics | 50.83M |
| Mereo BioPharma Group | 49.74M |
| Hyperion DeFi | 47.24M |
| Veraxa Biotech AG | 46.90M |
| Metagenomi Therapeutics | 46.84M |